Efficacy with ONTOZRY® (cenobamate)

This webpage is intended for UK-I health care professionals.

  This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events and product complaint should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard for the UK or www.hpra.ie for Ireland. Adverse events and product complaint should also be reported to Angelini Pharma on (UK) +44 2034889643, (IRE) +353 1 584 4671 or UKIReporting@angelinipharma.com
UK16608P | March 2023
  1. Home
  2. UK HCP
  3. You are here: Efficacy with ONTOZRY® (cenobamate)